Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Global Components and Global Enterprise Computing Solutions. The Global Components segment markets and distributes electronic components comprising semiconductor products and related services; interconnect, passive, and electromechanical products, including capacitors, resistors, potentiometers, power supplies, relays, switches, and connectors; and computing and memory products, as well as other products and services. The Global Enterprise Computing Solutions segment offers computing solutions, such as datacenter, cloud, security, and analytics solutions. This segment also provides access to various services, including engineering and integration support, warehousing and logistics, marketing resources, and authorized hardware and software training. It serves original equipment manufacturers, value-added resellers, managed service providers, contract manufacturers, and other commercial customers. The company was founded in 1935 and is based in Centennial, Colorado.

Arrow Electronics Inc.

Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Arrowhead Pharmaceuticals yesterday and set a price target of $81.00. ...

Bank of America Securities Sticks to Their Buy Rating for Arrowhead Pharmaceuticals (ARWR)

Jefferies analyst maintained a Buy rating on Arrowhead Pharmaceuticals today and set a price target of $67.00. In addition to Jefferies, Arrowhead ...

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from Jefferies

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR – Research Report)...

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), Cytokinetics (CYTK) and Denali Therapeutics (DNLI)

Arway Corp. ( ($TSE:ARWY) ) just unveiled an announcement. ARway Corp. has announced a definitive agreement for Nextech3D.ai to acquire all outstan...

Nextech3D.ai to Acquire Full Stake in ARway Corp., Enhancing AR Navigation Solutions

Arrowhead Pharmaceuticals, Inc. ( ($ARWR) ) has released its Q4 earnings. Here is a breakdown of the information Arrowhead Pharmaceuticals, Inc. pr...

Arrowhead Pharmaceuticals Reports Transformative Year-End Results

In a report released today, from B. Riley Securities reiterated a Buy rating on Arrowhead Pharmaceuticals, with a price target of $61.00. In additi...

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from B. Riley Securities

An announcement from Arrowhead Pharmaceuticals ( ($ARWR) ) is now available. On November 18, 2025, Arrowhead Pharmaceuticals announced that the FDA...

Arrowhead Pharmaceuticals’ REDEMPLO Approved by FDA

Arway Corp. ( ($TSE:ARWY) ) has shared an announcement. Arway Corporation has announced the completion of its previously planned issuance of 1,483,...

Arway Corp Completes Share Issuance for Past Services

Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio...

Current Quarter	$3.55	Next Quarter	$2.35
Current Year	$10.19	Next Year	$11.86
QoQ Growth	-33.8%	YoY Growth	+16.4%
3Y EPS CAGR	-21.6%	Target Price	$108.25
Consensus	Buy	Upside	-4.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ARW	$113.59	-1.40%	478.33K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ARW	$113.59	-1.4%	478.33K
3
4
5
6

ARW

ARW

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Arrow Electronics Inc. Data in Excel

Get Arrow Electronics Inc. Data in Excel